U.S. Supreme Court backs quicker approval of drug copies
Monday, June 12, 2017 - 15:02
in Mathematics & Economics
The U.S. Supreme Court unanimously ruled Monday that biotech drug copies -- called biosimilars -- can become available to consumers quicker.